BID | 248.76 | ASK | 263.24 | ||
Open | 253.37 | Previous Close | 255.91 | ||
Pre-Market | - | After-Market | 255.91 | ||
- - | - -% |
Target Price | 346.92 | Analyst Rating | Moderate Buy 2.25 | |
Potential % | 35.56 | Finscreener Ranking | ★ 41.89 | |
Insiders Trans % 3/6/12 mo. | -100/-100/-87 | Value Ranking | ★+ 43.30 | |
Insiders Value % 3/6/12 mo. | -100/-100/-98 | Growth Ranking | ★★★★ 59.12 | |
Insiders Shares Cnt. % 3/6/12 mo. | -100/-100/-98 | Income Ranking | ★ 31.89 | |
Price Range Ratio 52W % | 12.23 | Earnings Rating | Neutral | |
Market Cap | 12.00B | Earnings Date | 28th Jul 2022 | |
Alpha | -0.00 | Standard Deviation | 0.08 | |
Beta | 1.16 |
Today's Price Range 253.01257.31 | 52W Range 235.01405.90 | 5 Year PE Ratio Range 22.6088.30 |
Summary:
Sell
Technical Indicators: | Neutral |
Moving Averages: | Strong Sell |
Performance | |||
---|---|---|---|
1 Week | 2.02% | ||
1 Month | 0.49% | ||
3 Months | -1.46% | ||
6 Months | -22.95% | ||
1 Year | -34.21% | ||
3 Years | -31.14% | ||
5 Years | 21.51% | ||
10 Years | 324.41% |
Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
ROE (5Y Avg) | 9.05 | |||
ROE last 12 Months | 13.97 | |||
ROA (5Y Avg) | 3.65 | |||
ROA last 12 Months | 7.22 | |||
ROC (5Y Avg) | 6.35 | |||
ROC last 12 Months | 9.15 | |||
Return on invested Capital Q | 1.49 | |||
Return on invested Capital Y | 2.40 | |||
Assets Turnover | 0.30 | |||
Receivables Turnover | 5.50 |
Valuation | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
23.70 | ||||
3.02 | ||||
5.45 | ||||
19.20 | ||||
18.80 | ||||
12.71 | ||||
-12.17 | ||||
80.93 | ||||
12.94B | ||||
Forward PE | 16.76 | |||
PEG | 2.21 |
Financial Strength | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
1.30 | ||||
2.30 | ||||
0.33 | ||||
0.52 | ||||
12.20 | ||||
Leverage Ratio | 1.80 |
Profitability | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
55.10 | ||||
21.90 | ||||
30.20 | ||||
13.60 | ||||
18.97 |
Revenue | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
2.10B | ||||
44.86 | ||||
3.58 | ||||
6.67 |
Dividends | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
0.56 | ||||
1.36 | ||||
0.00 | ||||
0.00 | ||||
Payout ratio | 23.00 |
Earnings History | Estimate | Reported | Surprise % |
---|---|---|---|
Q02 2022 | 3.35 | 3.39 | 1.19 |
Q01 2022 | 2.73 | 2.88 | 5.49 |
Q04 2021 | 3.53 | 3.60 | 1.98 |
Q03 2021 | 3.03 | 3.51 | 15.84 |
Q02 2021 | 2.86 | 3.35 | 17.13 |
Q01 2021 | 2.44 | 2.87 | 17.62 |
Q04 2020 | 3.03 | 3.25 | 7.26 |
Q03 2020 | 2.27 | 2.77 | 22.03 |
Earnings Per End | Estimate | Revision % | Trend |
---|---|---|---|
6/2022 QR | 3.35 | -0.89 | Negative |
9/2022 QR | 3.59 | -2.71 | Negative |
12/2022 FY | 13.94 | -0.43 | Negative |
12/2023 FY | 15.26 | -1.68 | Negative |
Next Report Date | - |
Estimated EPS Next Report | 3.35 |
Estimates Count | 13 |
EPS Growth Next 5 Years % | 10.70 |
Volume Overview | |
---|---|
Volume | 315.26K |
Shares Outstanding | 46.91K |
Shares Float | 30.41M |
Trades Count | 6.38K |
Dollar Volume | 80.35M |
Avg. Volume | 513.96K |
Avg. Weekly Volume | 574.06K |
Avg. Monthly Volume | 541.50K |
Avg. Quarterly Volume | 426.30K |
Teleflex Incorporated (NYSE: TFX) stock closed at 255.91 per share at the end of the most recent trading day (a 2.13% change compared to the prior day closing price) with a volume of 315.26K shares and market capitalization of 12.00B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 14000 people. Teleflex Incorporated CEO is Liam J. Kelly.
The one-year performance of Teleflex Incorporated stock is -34.21%, while year-to-date (YTD) performance is -22.09%. TFX stock has a five-year performance of 21.51%. Its 52-week range is between 235.01 and 405.895, which gives TFX stock a 52-week price range ratio of 12.23%
Teleflex Incorporated currently has a PE ratio of 23.70, a price-to-book (PB) ratio of 3.02, a price-to-sale (PS) ratio of 5.45, a price to cashflow ratio of 19.20, a PEG ratio of 2.32, a ROA of 7.22%, a ROC of 9.15% and a ROE of 13.97%. The company’s profit margin is 18.97%, its EBITDA margin is 30.20%, and its revenue ttm is $2.10 Billion , which makes it $44.86 revenue per share.
Of the last four earnings reports from Teleflex Incorporated, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $3.35 for the next earnings report. Teleflex Incorporated’s next earnings report date is -.
The consensus rating of Wall Street analysts for Teleflex Incorporated is Moderate Buy (2.25), with a target price of $346.92, which is +35.56% compared to the current price. The earnings rating for Teleflex Incorporated stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Teleflex Incorporated has a dividend yield of 0.56% with a dividend per share of $1.36 and a payout ratio of 23.00%.
Teleflex Incorporated has a Sell technical analysis rating based on Technical Indicators (ADX : 7.73, ATR14 : 8.22, CCI20 : -15.97, Chaikin Money Flow : 0.31, MACD : -1.56, Money Flow Index : 48.21, ROC : -2.79, RSI : 39.86, STOCH (14,3) : 44.77, STOCH RSI : 0.40, UO : 54.47, Williams %R : -55.23), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Teleflex Incorporated in the last 12-months were: Andrew A. Krakauer (Buy at a value of $153 732), Cameron P. Hicks (Option Excercise at a value of $435 600), Cameron P. Hicks (Sold 3 600 shares of value $1 260 000 ), Liam J. Kelly (Option Excercise at a value of $2 150 712), Liam J. Kelly (Sold 35 948 shares of value $12 695 366 ), Stuart A. Randle (Option Excercise at a value of $236 599), Stuart A. Randle (Sold 3 014 shares of value $853 896 )
Analyst Ratings | Current | 1 M ago | 3 M ago |
---|---|---|---|
Strong Buy | |||
Moderate Buy | |||
Hold | |||
Moderate Sell | |||
Strong Sell | |||
Summary Rating | Moderate Buy | Moderate Buy | Moderate Buy |
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (26% of 2020 sales), interventional (15%), surgical (13%), anesthesia (12%), interventional urology (13%), original-equipment manufacturing (7%), and all other (14%). Geographic exposure for the business is primarily in the U.S., which accounts for 60% of revenue, with international markets making up the remainder.
CEO: Liam J. Kelly
Telephone: +1 610 225-6800
Address: 550 East Swedesford Road, Wayne 19087, PA, US
Number of employees: 14 000
Mon, 01 Aug 2022 12:36 GMT Analysts Offer Insights on Healthcare Companies: Laboratory (LH), Teleflex (TFX) and Amedisys (AMED)
- TipRanks. All rights reserved.Fri, 15 Jul 2022 20:36 GMT Teleflex (TFX) Gets a Hold Rating from Morgan Stanley
- TipRanks. All rights reserved.Mon, 23 May 2022 12:55 GMT Teleflex (TFX) Gets a Buy Rating from Needham
- TipRanks. All rights reserved.Mon, 23 May 2022 12:35 GMT Analysts Offer Insights on Healthcare Companies: Teleflex (TFX), Intra-Cellular Therapies (ITCI) and Chinook Therapeutics (KDNY)
- TipRanks. All rights reserved.Mon, 17 Jan 2022 06:04 GMT Teleflex (TFX) Receives a Buy from RBC Capital
- TipRanks. All rights reserved.Copyright © 2016-2022 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
All rights reserved. Financial Market Data powered by Quotemedia.com. All rights reserved. View the Terms of Use. CBOE EDGX Top real-time data for Premium users, NYSE/NYSE MKT (AMEX) data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless otherwise indicated. Technology and data provided by TeleTrader. Conditions of Use. The regulations of the respective stock are to be observed. Copyright © 2022. All market data is provided by Quotemedia.com. Futures: at least a 10 minute delay. Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. To see all exchange delays and terms of use, please see disclaimer. The Cryptocurrency Market real-time data provided by Cryptocompare.com
Don´t have an account? Register
Looks like you are using AdBlock.
The revenue earned from advertising enables us to provide the quality content you are trying to reach on this website. In order to view this page, please disable AdBlock or purchase Premium.
Sign in if you already have Premium account.
This could take some time, please wait.